Heterosykliske forbindelser og deres fremstilling og anvendelse

Nye 9H-indeno[l,2-b]pyrazin-3(4H)- oner og 9H-indeno[l,2-b]pyrazin-2,3- (1H,4H)-dioner eller tautomere former derav som kan anvendes ved behandlingen av nevrologiske og psykiatriske sykdommer . The present invention relates to 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KLITGAARD, HENRIK, JAKOBSEN, PALLE, JORGENSEN, ANKER STEEN, FAARUP, PETER
Format:	Patent
Sprache:	nor
Schlagworte:	ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Nye 9H-indeno[l,2-b]pyrazin-3(4H)- oner og 9H-indeno[l,2-b]pyrazin-2,3- (1H,4H)-dioner eller tautomere former derav som kan anvendes ved behandlingen av nevrologiske og psykiatriske sykdommer . The present invention relates to 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof which are useful in treating neurological and psychiatric diseases based on the antagonism of the glycine binding site on the NMDA receptor complex.